Transforming growth factor beta-1 An important biomarker for developing cardiovascular diseases in chronic renal failure
Author(s) -
Emre Avcı,
Gülçin Alp Avcı,
Burçin Özçelik,
Şule Çoşkun Cevher,
Menderes Suíçmez
Publication year - 2017
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2017_035
Subject(s) - hemodialysis , medicine , pathogenesis , nephropathy , biomarker , chronic renal failure , diabetic nephropathy , renal function , transforming growth factor , kidney disease , cytokine , gastroenterology , endocrinology , urology , kidney , diabetes mellitus , biology , biochemistry
Our study focuses on the determination and evaluation of TGF-β1 levels of patients receiving hemodialysis treatment because of chronic renal failure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom